search query: @indexterm PHARMACEUTICAL INDUSTRY / total: 673
references: 24-33 / 673
« previous page | next page »
 titleyearauthor
24.
Ideas at work: sparkling innovation
Business Strategy Review
2010 : SUMMER, JUN, VOL. 21:2, p. 7-11
 2010 Birkinshaw, J.
Robbins, P.
25.
Garbage-can decision making and the accommodation of uncertainty in new drug development work
Creativity and innovation management
2010 : JUN, VOL. 19:2, p. 134-146
 2010 Styhre, A. (et al.)
26.
From recipe to dinner: Business model portfolios in the European biopharmaceutical industry
Long Range Planning
2010 : APR/JUN, VOL. 43:2-3, p. 431-447
 2010 Sabatier, V.
Mangematin, V.
Rousselle, T.
27.
Managing technological transitions through R&D alliances
R & D Management
2009 : MAR, VOL. 39:2, p. 124-135
 2009 Riccaboni, M.
Moliterni, R.
28.
Implementing Lean Sigma in pharmaceutical research and development: a review by practitioners
R & D Management
2009 : JAN, VOL. 39:1, p. 95-106
 2009 Carleysmith, S.W.
Dufton, A.M.
Altria, K.D.
29.
Exploring the internal and external venturing of large R&D-intensive firms
R & D Management
2009 : JUN, VOL. 39:3, p. 231-246
 2009 Williams, C.
Lee, S.H.
30.
Innovation and the welfare effects of public drug insurance
Journal of Public Economics
2009 : APR, VOL. 93:3-4, p. 541-548
 2009 Lakdawalla, D.
Sood, N.
31.
Pharmaceuticals in wastewater: Behavior, preferences, and willingness to pay for a disposal program
Journal of Environmental Management
2009 : MAR, VOL. 90:3, p. 1476-1482
 2009 Kotchen, M. (et al.)
32.
Collaboration – a competitor's tool: The story of Centocor, an entrepreneurial biotechnology company
Business history
2009 : JUL, VOL. 51:4 p. 529-546
 2009 Marks, L.V.
33.
Where strategy and ethics converge: pharmaceutical industry pricing policy for Medicare Part D beneficiaries
Journal of Business Ethics
2009 : VOL 84:SUPPL. 1, p. 75-88
 2009 Balotsky, E. R.
« previous page | next page »
SCIMA